Camargo Pharmaceutical Services, an end-to-end drug development company specializing in the 505(b)(2) process, has announced today its expansion into The Research Triangle Park (RTP) with the opening of a new office. The new location will pave the way for additional opportunities and service offerings, as well as streamlining client service.
Camargo’s decision to expand its reach to the east coast, specifically RTP, abides with the Company’s overall growth goals and global service coverage. RTP, the largest research park in the nation, is a 7,000-acre development that is home to more than 170 innovative companies. Located at the core of the Raleigh-Durham-Cary combined statistical area (CSA), RTP is a globally prominent high-technology research and development center that serves as an economic driver for the region.
“Opening a new office in The Research Triangle Park brings us the opportunity for growth in both our staff and services,” stated Ken Phelps, president and CEO of Camargo Pharmaceutical Services. “We continue to utilize our specialized regulatory expertise to increase service offerings, such as bio-better drug development – biologics that are enhanced over the reference products. Using our proven knowledge of how to improve small molecule drugs, we can provide unique regulatory and program management services for preclinical and clinical trials for biologic-based drugs.”
Camargo is focused on global drug development through the 505(b)(2) process and provides a full spectrum of services from discovery through each phase of clinical development.
